ResMed Inc. (RMD) Launches Global Sleep Institute at World Sleep Congress

Company Overview - ResMed Inc. (NYSE:RMD) is a leading health technology company focused on sleep, breathing, and home care solutions, developing innovative devices and digital platforms for patients with sleep apnea and chronic respiratory conditions [1] - The company aims to improve patient outcomes globally by combining medical expertise with advanced technology [1] Recent Developments - In 2025, ResMed launched its Sleep Institute at the World Sleep Congress, aiming to advance sleep health through partnerships with various stakeholders, focusing on evidence-based insights to drive care innovation [2] - The initiative addresses the global burden of sleep disorders, particularly obstructive sleep apnea (OSA) and insomnia, which are often undiagnosed [2] Research and Trends - Research presented at the SLEEP 2025 conference highlighted trends such as PAP therapy adherence, gender disparities in OSA diagnosis, patient-reported outcomes, and the role of artificial intelligence in enhancing therapy engagement [3] - These developments position ResMed as a strong growth potential player in the health technology sector through innovation in devices and digital health solutions [3] Strategic Acquisitions - ResMed acquired VirtuOx, an independent diagnostic testing facility specializing in at-home diagnostics for sleep, respiratory, and cardiac conditions, enhancing its capabilities in early diagnosis and connected home-based care [4] - This acquisition simplifies patient access and supports better health outcomes [4]